M&A Deal Summary |
|
---|---|
Date | 2018-07-05 |
Target | Cryterion Medical |
Sector | Life Science |
Buyer(s) | Boston Scientific |
Deal Type | Add-on Acquisition |
Deal Value | 202M USD |
SEARCH BY
Try For Free 7-Day Free Trial
Category | Company |
---|---|
Founded | 1979 |
Sector | Medical Products |
Employees | 48,000 |
Revenue | 14.2B USD (2023) |
Boston Scientific is a medical technology company. Boston Scientific's products and technologies are used to diagnose or treat a wide range of medical conditions, including heart, digestive, pulmonary, vascular, urological, women's health, and chronic pain conditions. Boston Scientific was founded in 1979 and is based in Marlborough, Massachusetts.
DEAL STATS | # |
---|---|
Overall | 48 of 66 |
Sector (Life Science) | 5 of 6 |
Type (Add-on Acquisition) | 37 of 51 |
State (Wisconsin) | 1 of 1 |
Country (United States) | 38 of 51 |
Year (2018) | 6 of 10 |
Size (of disclosed) | 23 of 34 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2018-04-16 |
nVision Medical
San Bruno, California, United States nVision Medical Corp. is a developer of medical device which collect cells from the fallopian tubes, offering a potential platform for earlier diagnosis of ovarian cancer. nVision Medical was founded in 2011 and is based in San Bruno, California. |
Buy | $150M |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2018-07-20 |
Claret Medical
Santa Rosa, California, United States Claret Medical, Inc. is a developer and commercialized the sentinel cerebral embolic protection system. Claret Medical was founded in 2009 and is based in Santa Rosa, California. |
Buy | $220M |